Cost-utility analysis of aprepitant for patients who truly need it in a Japanese health care setting.

被引：0
|
作者：
Tsukiyama, Ikuto
Ando, Masahiko
Tsukiyama, Sumiyo
Takeuchi, Masayuki
Ejiri, Masayuki
Yamamoto, Yoshihiro
Asai, Nobuhiro
Saito, Hiroko
Arakawa, Ichiro
Inoue, Tadao
Matsuura, Katsuhiko
Kubo, Akihito
机构：
[1] Aichi Med Univ Hosp, Dept Pharm, Nagakute, Aichi, Japan
[2] Nagoya Univ Hosp, Ctr Adv Med & Clin Res, Nagoya, Aichi, Japan
[3] Aichi Med Univ, Div Resp Med & Allergol, Sch Med, Aichi, Japan
[4] Meijo Univ, Fac Pharm, Nagoya, Aichi, Japan
[5] Teikyo Heisei Univ, Fac Pharmaceut Sci, Tokyo, Japan
[6] Ohu Univ, Sch Pharmaceut Sci, Fukushima, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 15期
关键词：
D O I：
10.1200/JCO.2016.34.15_suppl.e18243
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e18243
引用
收藏
页数：4
相关论文
共 50 条
  • [1] Cost-utility analysis of aprepitant for patients who truly need it in Japan
    Tsukiyama, Ikuto
    Ando, Masahiko
    Tsukiyama, Sumiyo
    Takeuchi, Masayuki
    Ejiri, Masayuki
    Kurose, Yusuke
    Saito, Hiroko
    Arakawa, Ichiro
    Inoue, Tadao
    Yamaguchi, Etsuro
    Kubo, Akihito
    SUPPORTIVE CARE IN CANCER, 2019, 27 (10) : 3749 - 3758
  • [2] Cost-utility analysis of aprepitant for patients who truly need it in Japan
    Ikuto Tsukiyama
    Masahiko Ando
    Sumiyo Tsukiyama
    Masayuki Takeuchi
    Masayuki Ejiri
    Yusuke Kurose
    Hiroko Saito
    Ichiro Arakawa
    Tadao Inoue
    Etsuro Yamaguchi
    Akihito Kubo
    Supportive Care in Cancer, 2019, 27 : 3749 - 3758
  • [3] Therapeutic and preventive antiemetic effect of aprepitant in Japanese patients with thoracic malignancies who truly need it
    Ito, Sumiyo
    Tsukiyama, Ikuto
    Ando, Masahiko
    Katakami, Masayo
    Hamanaka, Rie
    Kosaka, Kenshi
    Matsubara, Ayako
    Nishimura, Masaki
    Tanaka, Hiroyuki
    Asai, Nobuhiro
    Yokoe, Norihito
    Takahashi, Ayumu
    Baba, Kenji
    Matsuura, Katsuhiko
    Yamaguchi, Etsuro
    Kubo, Akihito
    SUPPORTIVE CARE IN CANCER, 2015, 23 (04) : 905 - 912
  • [4] Therapeutic and preventive antiemetic effect of aprepitant in Japanese patients with thoracic malignancies who truly need it
    Sumiyo Ito
    Ikuto Tsukiyama
    Masahiko Ando
    Masayo Katakami
    Rie Hamanaka
    Kenshi Kosaka
    Ayako Matsubara
    Masaki Nishimura
    Hiroyuki Tanaka
    Nobuhiro Asai
    Norihito Yokoe
    Ayumu Takahashi
    Kenji Baba
    Katsuhiko Matsuura
    Etsuro Yamaguchi
    Akihito Kubo
    Supportive Care in Cancer, 2015, 23 : 905 - 912
  • [5] COST-UTILITY ANALYSIS IN THE EVALUATION OF PERINATAL HEALTH-CARE
    DERHAM, R
    LANCET, 1986, 2 (8503): : 399 - 399
  • [6] The QALY model: Utilities for cost-utility analysis in health care
    Fryback, DG
    DECISION SCIENCE AND TECHNOLOGY: REFLECTIONS ON THE CONTRIBUTIONS OF WARD EDWARDS, 1999, : 331 - 351
  • [7] COST-UTILITY ANALYSIS OF CANCER CARE
    OESER, H
    KOEPPE, P
    MUNCHENER MEDIZINISCHE WOCHENSCHRIFT, 1984, 126 (09): : A38 - &
  • [8] Cost-effectiveness analysis of aprepitant in Japanese patients who received highdose cisplatin
    Tsukiyama, Ikuto
    Hasegawa, Shiori
    Ikeda, Yoshiaki
    Takeuchi, Masayuki
    Tsukiyama, Sumiyo
    Sakuma, Masaki
    Kurose, Yusuke
    Ejiri, Masayuki
    Arakawa, Ichiro
    Inoue, Tadao
    Saito, Hiroko
    Yamaguchi, Etsuro
    Kubo, Akihito
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [9] Assessing Health Gains: A Cost-Utility Analysis
    Guarducci, G.
    Siragusa, C.
    Gurnari, J.
    Gentile, A. M.
    Nante, N.
    EUROPEAN JOURNAL OF PUBLIC HEALTH, 2024, 34
  • [10] Preferences for health outcomes and cost-utility analysis
    Torrance, GW
    AMERICAN JOURNAL OF MANAGED CARE, 1997, 3 : S8 - S20
12345